A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia - Hosonuma, K; Sato, K; Yamazaki, Y (Am J Gastroenterol, 2015)
et al.